Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 192 Total
AONC - American Oncology Network, Inc. - Stock Price Chart
CompanyAmerican Oncology Network, Inc.
IndustryMedical Care Facilities
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume222.08K52W Range7.02 - 39.60
The American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most - providing the highest quality care for patients.
SCHL - Scholastic Corporation - Stock Price Chart
CompanyScholastic Corporation
Market Cap1.13BEPS (ttm)2.48
P/E13.65EPS this Y9.70%
Forward P/E10.83EPS next Y18.18%
PEG1.50EPS past 5Y162.30%
P/S0.66EPS next 5Y9.10%
P/B0.95EPS Q/Q54.70%
Dividend2.37%Sales Q/Q2.70%
Insider Own1.10%Inst Own88.40%
Insider Trans-1.22%Inst Trans-1.12%
Short Float3.65%EarningsSep 21/a
Analyst Recom-Target Price57.00
Avg Volume208.46K52W Range28.22 - 47.25
Scholastic Corporation publishes and distributes children's books worldwide. It operates in three segments: Children's Book Publishing and Distribution, Education Solutions, and International. The Children's Book Publishing and Distribution segment engages in publication and distribution of children's books, eBooks, media, and interactive products through its school book clubs and fair channels, and trade channel. Its original publications include the Harry Potter, Hunger Games, Bad Guys, Baby-Sitters Club graphic novels, Magic School Bus, Captain Underpants, Dog Man, Wings of Fire, Cat Kid Comic Club, Goosebumps, and Clifford The Big Red Dog; and licensed properties comprise the Peppa Pig and Pokemon. In addition, this segment publishes and creates books plus and novelty products for children, including titles, such as the Pastel Studio, Mini Clay World Candy Cart, LEGO Gear Bots, Never Touch series, and other titles under the Klutz and the Make Believe Ideas names; and non-fiction books under the Children's Press and Franklin Watts names. The Education Solutions segment publishes and distributes classroom magazines under the Scholastic News, Scholastic Scope, Storyworks, Let's Find Out, and Junior Scholastic names; supplemental and classroom materials and programs, and related support services; and print and on-line reference, and non-fiction products, as well as consulting services. The International segment publishes and distributes English and French language children's books; and operates school-based marketing channels, as well as supply original and licensed children's books, and supplemental educational materials including professional books for teachers. The company distributes its products and services directly to schools and libraries through retail stores and the Internet. Scholastic Corporation was founded in 1920 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILLIAMS MARGARET ADirectorSep 18Option Exercise30.562,74683,91820,762Sep 20 04:07 PM
BARGE JAMES WDirectorSep 18Option Exercise30.562,74683,91826,128Sep 20 05:22 PM
DAVIES JOHN LDirectorAug 02Sale43.684,530197,8703,930Aug 04 04:03 PM
Peter WarwickPRESIDENT & CEOSep 27Buy31.033,245100,69271,218Sep 28 06:38 PM
WE - WeWork Inc. - Stock Price Chart
TickerWE [NYSE]
CompanyWeWork Inc.
IndustryReal Estate Services
Market Cap165.09MEPS (ttm)-7.77
P/E-EPS this Y56.90%
Forward P/E-EPS next Y60.80%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B-EPS Q/Q71.70%
Dividend-Sales Q/Q3.60%
Insider Own0.40%Inst Own87.10%
Insider Trans-98.92%Inst Trans-
Short Float4.49%EarningsAug 09/b
Analyst Recom3.00Target Price10.00
Avg Volume3.45M52W Range2.61 - 134.80
Sep-20-23 05:23PM Detroit Auto Show, UAW Strike, and Workers' Return to the Office (Motley Fool) -6.68%
Sep-19-23 05:54AM ZIRP: good, actually! (Financial Times)
Sep-13-23 10:43AM WeWork stock, Citi reorganization, Adobe AI: Top Stocks (Yahoo Finance Video) -10.45%
Sep-06-23 07:06PM WeWork Looks to Renegotiate Most of Its Leases as It Fights to Survive (The Wall Street Journal)
03:21PM WeWork renegotiates leases, expects to exit unfit locations (Yahoo Finance Video)
Sep-05-23 04:38PM WeWork reverse stock split, Mastercard fees: Trending Tickers (Yahoo Finance Video) -19.55%
Sep-01-23 04:15PM WeWork Inc. Announces Completion of 1-for-40 Reverse Stock Split (Business Wire) -6.78%
Aug-24-23 02:05PM Wall Street Funds Discuss Potential Bankruptcy Plan for WeWork (The Wall Street Journal) +12.69%
Aug-23-23 01:49PM WeWork Taps Restructuring Advisers in Effort to Stave Off Bankruptcy (Bloomberg) -5.93%
Aug-18-23 10:32AM Hawaiian Electric, MSG Entertainment, WeWork: Trending stocks (Yahoo Finance Video) -11.27%
WeWork Inc. provides flexible workspace solutions to individuals and organizations worldwide. The company offers workstation, private office, and customized floor solutions; and various amenities and services, such as private phone booths, internet, high-speed business printers and copiers, mail and package handling, front desk services, off-peak building access, common areas, and daily enhanced cleaning solutions. It also provides various value-add services; business and technical service solutions, including professional employer organization and payroll services, remote workforce solutions, human resources benefits, dedicated bandwidth, and IT equipment co-location solutions. In addition, the company offers WeWork All Access, a monthly subscription-based model that allows members to book workspaces, conference rooms, and private offices; WeWork On Demand, which enables users with pay-as-you-go access to book individual workspace or conference rooms at nearby WeWork locations; and WeWork Workplace, a turnkey workspace management solution for landlords, operators, and enterprises. WeWork Inc. was founded in 2010 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wehner KurtChief Financial OfficerSep 15Sale4.251,3915,9125,436Sep 19 04:18 PM
DUNLEVIE BRUCE10% OwnerAug 16Sale0.164,329,355687,0699,735,654Aug 17 05:27 PM
Benchmark Capital Management C10% OwnerAug 16Sale0.164,329,355687,0699,735,654Aug 17 05:26 PM
Benchmark Capital Management C10% OwnerAug 15Sale0.205,406,3011,082,88214,065,009Aug 17 05:26 PM
DUNLEVIE BRUCE10% OwnerAug 15Sale0.205,406,3011,082,88214,065,009Aug 17 05:27 PM
AVGR - Avinger, Inc. - Stock Price Chart
CompanyAvinger, Inc.
IndustryMedical Instruments & Supplies
Market Cap6.97MEPS (ttm)-30.42
P/E-EPS this Y4.60%
Forward P/E-EPS next Y56.10%
PEG-EPS past 5Y80.40%
P/S0.85EPS next 5Y-
P/B-EPS Q/Q37.00%
Dividend-Sales Q/Q-4.80%
Insider Own0.20%Inst Own14.10%
Insider Trans-13.44%Inst Trans-
Short Float0.62%EarningsJul 27/a
Analyst Recom2.00Target Price24.00
Avg Volume1.84M52W Range4.14 - 24.30
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Subainati Nabeel PaulVice President, FinanceMar 23Sale0.8122318185,672Mar 24 04:36 PM
CMMB - Chemomab Therapeutics Ltd. - Stock Price Chart
CompanyChemomab Therapeutics Ltd.
Market Cap10.64MEPS (ttm)-47.23
P/E-EPS this Y-102.00%
Forward P/E-EPS next Y25.00%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.03EPS Q/Q-32.50%
Dividend-Sales Q/Q-
Insider Own2.90%Inst Own34.60%
Insider Trans0.00%Inst Trans-0.89%
Short Float0.37%EarningsAug 14/b
Analyst Recom3.00Target Price-
Avg Volume70.41K52W Range1.00 - 5.35
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody had completed Phase 2a clinical trials that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 2021. Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OrbiMed Israel GP Ltd.10% OwnerJan 03Sale3.58336,9001,207,7592,241,274Jan 05 04:49 PM
Mor George AdiChief Scientific OfficerJan 03Sale5.037,70038,706317,075Jan 05 04:01 PM
Mor George AdiChief Scientific OfficerJan 03Sale5.036,10030,663251,147Jan 05 04:01 PM
Mor George AdiChief Scientific OfficerNov 16Sale2.08324,775677,091324,775Nov 17 04:56 PM
Mor George AdiChief Scientific OfficerNov 16Sale2.08257,248536,311257,247Nov 17 04:56 PM
AUTL - Autolus Therapeutics plc - Stock Price Chart
CompanyAutolus Therapeutics plc
CountryUnited Kingdom
Market Cap409.22MEPS (ttm)-1.21
P/E-EPS this Y20.50%
Forward P/E-EPS next Y16.70%
PEG-EPS past 5Y-2.00%
P/S54.56EPS next 5Y-
P/B1.77EPS Q/Q43.40%
Dividend-Sales Q/Q-
Insider Own8.45%Inst Own30.20%
Insider Trans0.00%Inst Trans-2.77%
Short Float0.86%EarningsAug 03/b
Analyst Recom2.00Target Price8.48
Avg Volume437.35K52W Range1.60 - 3.54
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma. It also focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.
SIEN - Sientra, Inc. - Stock Price Chart
CompanySientra, Inc.
IndustryMedical Devices
Market Cap28.41MEPS (ttm)-6.51
P/E-EPS this Y6.80%
Forward P/E-EPS next Y45.40%
PEG-EPS past 5Y7.90%
P/S0.30EPS next 5Y20.00%
P/B-EPS Q/Q71.00%
Dividend-Sales Q/Q7.40%
Insider Own0.90%Inst Own27.80%
Insider Trans0.00%Inst Trans-81.80%
Short Float17.62%EarningsAug 10/a
Analyst Recom1.70Target Price6.33
Avg Volume336.16K52W Range1.25 - 8.88
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California.
CUTR - Cutera, Inc. - Stock Price Chart
CompanyCutera, Inc.
IndustryMedical Devices
Market Cap144.84MEPS (ttm)-3.90
P/E-EPS this Y-232.20%
Forward P/E-EPS next Y10.40%
PEG-EPS past 5Y-30.20%
P/S0.59EPS next 5Y25.00%
P/B-EPS Q/Q37.00%
Dividend-Sales Q/Q-4.70%
Insider Own1.10%Inst Own131.60%
Insider Trans17.99%Inst Trans-0.62%
Short Float30.06%EarningsAug 08/a
Analyst Recom2.70Target Price23.00
Avg Volume740.15K52W Range7.83 - 52.89
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harris Taylor C.Chief Executive OfficerAug 29Buy9.9130,000297,300279,336Aug 30 08:57 AM
Drummond StuartInterim CFOAug 29Buy9.805,00049,00019,678Aug 30 08:56 AM
RVYL - Ryvyl Inc. - Stock Price Chart
CompanyRyvyl Inc.
IndustrySoftware - Infrastructure
Market Cap17.08MEPS (ttm)-7.37
P/E-EPS this Y-24.70%
Forward P/E-EPS next Y88.20%
PEG-EPS past 5Y-
P/S0.36EPS next 5Y-
P/B-EPS Q/Q-183.00%
Dividend-Sales Q/Q111.40%
Insider Own-Inst Own6.70%
Insider Trans-Inst Trans-
Short Float1.16%EarningsAug 14/a
Analyst Recom3.00Target Price-
Avg Volume57.23K52W Range2.70 - 17.50
Ryvyl Inc., a technology company, engages in the development, marketing, and sale of blockchain-based payment solutions. The company's blockchain-based systems facilitate, record, and store a volume of tokenized assets representing cash or data on a blockchain-based ledger. Its products include QuickCard Payment System, a physical and virtual payment card processing management system, including software that facilitates on and off ramp e-wallet management; point of sale solutions comprising software and hardware; and Coyni, a digital currency platform that is backed on a 1:1 ratio to the U.S. Dollar, which offers custodial assurance by utilizing its stable coin and blockchain technology in a closed-loop ecosystem. The company's brands include coyni, QuickCard, and ChargeSavvy. It serves customers in various industries, including foreign exchange, retail, and e-commerce sectors. The company was formerly known as GreenBox POS and changed its name to Ryvyl Inc. in October 2022. Ryvyl Inc. is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Laniado EzraDirectorDec 15Buy0.509,9904,99550,586Dec 20 04:39 PM
VAPO - Vapotherm, Inc. - Stock Price Chart
CompanyVapotherm, Inc.
IndustryMedical Devices
Market Cap15.09MEPS (ttm)-19.84
P/E-EPS this Y-83.80%
Forward P/E-EPS next Y48.00%
PEG-EPS past 5Y-17.90%
P/S0.23EPS next 5Y10.60%
P/B-EPS Q/Q81.80%
Dividend-Sales Q/Q23.10%
Insider Own8.20%Inst Own55.70%
Insider Trans-Inst Trans-
Short Float3.42%EarningsAug 08/a
Analyst Recom3.30Target Price2.00
Avg Volume39.06K52W Range2.55 - 23.65
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Army JosephPresident and CEOSep 08Buy3.5378,013275,235392,096Sep 11 10:10 AM
Army JosephPresident and CEOSep 07Buy3.3121,98772,757314,083Sep 11 10:10 AM
Arnerich Anthony L.DirectorAug 31Buy3.1720,00063,304243,374Aug 31 04:47 PM
Arnerich Anthony L.DirectorAug 31Buy3.1012,75039,53371,826Aug 31 04:47 PM
Arnerich Anthony L.DirectorAug 30Buy2.905,00014,50059,076Aug 31 04:47 PM